# Study of JTM104 Injection vs. Juvederm in Treating Moderate to Severe Nasolabial Folds

> **NCT07265791** · NA · NOT_YET_RECRUITING · sponsor: **Jetema Co., Ltd.** · enrollment: 100 (estimated)

## Conditions studied

- Nasolabial Folds, Wrinkles

## Interventions

- **BIOLOGICAL:** JTM104
- **BIOLOGICAL:** Juvederm® ULTRA PLUS XC

## Key facts

- **NCT ID:** NCT07265791
- **Lead sponsor:** Jetema Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-03
- **Primary completion:** 2026-06-30
- **Final completion:** 2027-01-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07265791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07265791, "Study of JTM104 Injection vs. Juvederm in Treating Moderate to Severe Nasolabial Folds". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07265791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*